Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vita Life Sciences Limited ( (AU:VLS) ) has issued an update.
Vita Life Sciences Limited has reported a robust performance for the first half of 2025, underscoring the effectiveness of its strategic approach and product offerings. The company remains focused on sustaining growth through strategic investments in its brands and markets, reflecting a commitment to strengthening its market position and delivering value to stakeholders.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Average Trading Volume: 12,438
Technical Sentiment Signal: Buy
Current Market Cap: A$119.4M
For detailed information about VLS stock, go to TipRanks’ Stock Analysis page.

